Innate immune cell networking in hepatitis C virus infection

Journal of Leukocyte Biology

Volumn 96, Issue 5, 2014, Pages 757-766

  Saha, Banishree ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Chronic; Dendritic cells; Macrophages; Monocytes; NK cells; Sensors

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; CELL INTERACTION; HEPATITIS C; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; REVIEW; SENSOR; VIRAL CLEARANCE; ANIMAL; CELL COMMUNICATION; HEPACIVIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELL COMMUNICATION; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE;

EID: 84908287136     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4MR0314-141R     Document Type: Review

References (137)

1. Gane, E. J. (2008) The natural history of recurrent hepatitis C and what influences this. Liver Transpl. 14 (Suppl. 2), S36–S44.
2. Liang, T. J., Rehermann, B., Seeff, L. B., Hoofnagle, J. H. (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132, 296–305.
3. Hofmann, W. P., Zeuzem, S. (2011) Hepatitis C in 2011: a new standard of care and the race towards IFN-free therapy. Nat. Rev. Gastroenterol. Hepatol. 9, 67–68.
4. Rose, R., Markov, P. V., Lam, T. T., Pybus, O. G. (2013) Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation. Infect. Genet. Evol. 20, 418–421.
5. Kuiken, C., Simmonds, P. (2009) Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 510, 33–53.
6. Smith, D. B., Bukh, J., Kuiken, C., Muerhoff, A. S., Rice, C. M., Stapleton, J. T., Simmonds, P. (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 59, 318–327.
7. Bukh, J., Miller, R. H., Purcell, R. H. (1995) Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15, 41–63.
8. Gentzsch, J., Brohm, C., Steinmann, E., Friesland, M., Menzel, N., Vieyres, G., Perin, P. M., Frentzen, A., Kaderali, L., Pietschmann, T. (2013) Hepatitis C virus p7 is critical for capsid assembly and envelopment. PLoS Pathog. 9, e1003355.
9. Nakai, K., Okamoto, T., Kimura-Someya, T., Ishii, K., Lim, C. K., Tani, H., Matsuo, E., Abe, T., Mori, Y., Suzuki, T., Miyamura, T., Nunberg, J. H., Moriishi, K., Matsuura, Y. (2006) Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J. Virol. 80, 11265–11273.
10. Vieyres, G., Thomas, X., Descamps, V., Duverlie, G., Patel, A. H., Dubuisson, J. (2010) Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J. Virol. 84, 10159–10168.
11. Scheel, T. K., Rice, C. M. (2013) Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19, 837–849.
12. Wherry, E. J. (2011) T cell exhaustion. Nat. Immunol. 12, 492–499.
13. Eksioglu, E. A. (2012) Hepatitis C virus’ initial encounters: mechanisms of innate immunity. Front. Biosci. (Landmark Ed). 17, 281–299.
14. Ng, C. T., Snell, L. M., Brooks, D. G., Oldstone, M. B. (2013) Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 13, 652–664.
15. Cheent, K., Khakoo, S. I. (2011) Natural killer cells and hepatitis C: action and reaction. Gut 60, 268–278.
16. Rosen, H. R. (2013) Emerging concepts in immunity to hepatitis C virus infection. J. Clin. Invest. 123, 4121–4130.
17. Park, S. H., Rehermann, B. (2014) Immune responses to HCV and other hepatitis viruses. Immunity 40, 13–24.
18. Horner, S. M. (2014) Activation and evasion of antiviral innate immunity by hepatitis C virus. J. Mol. Biol. 426, 1198–1209.
19. Imran, M., Waheed, Y., Manzoor, S., Bilal, M., Ashraf, W., Ali, M., Ashraf, M. (2012) Interaction of hepatitis C virus proteins with pattern recognition receptors. Virol. J. 9, 126.
20. Lester, S. N., Li, K. (2014) Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426, 1246–1264.
21. Szabo, G., Dolganiuc, A. (2008) Hepatitis C and innate immunity: recent advances. Clin. Liver Dis. 12, 675–692.
22. Takeda, K., Akira, S. (2004) TLR signaling pathways. Semin. Immunol. 16, 3–9.
23. Barton, G. M., Kagan, J. C. (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 9, 535–542.
24. Siednienko, J., Miggin, S. M. (2009) Expression analysis of the Toll-like receptors in human peripheral blood mononuclear cells. Methods Mol. Biol. 517, 3–14.
25. Dolganiuc, A., Garcia, C., Kodys, K., Szabo, G. (2006) Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J. Gastroenterol. 12, 1198–1204.
26. Sato, K., Ishikawa, T., Okumura, A., Yamauchi, T., Sato, S., Ayada, M., Matsumoto, E., Hotta, N., Oohashi, T., Fukuzawa, Y., Kakumu, S. (2007) Expression of Toll-like receptors in chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 22, 1627–1632.
27. Chang, S., Dolganiuc, A., Szabo, G. (2007) Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J. Leukoc. Biol. 82, 479–487.
28. Zhang, Y. L., Guo, Y. J., Bin, L., Sun, S. H. (2009) Hepatitis C virus single- stranded RNA induces innate immunity via Toll-like receptor 7. J. Hepatol. 51, 29–38.
29. Takahashi, K., Asabe, S., Wieland, S., Garaigorta, U., Gastaminza, P., Isogawa, M., Chisari, F. V. (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc. Natl. Acad. Sci. USA 107, 7431–7436.
30. Saha, B., Szabo, G. (2013, November 1–5) HCV induces differentiation of CD14+ circulating monocytes via TLR8 into macrophage-like cells that exhibit M2 (alternative) polarization and profibrogenic effects. American Association for the Study of Liver Diseases, The Liver Meeting, Washington, DC, USA (abs.).
31. Chang, S., Kodys, K., Szabo, G. (2010) Impaired expression and function of Toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 51, 35–42.
32. Yang, L., Seki, E. (2012) Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front. Physiol. 3, 138.
33. Tsutsui, H., Matsui, K., Okamura, H., Nakanishi, K. (2000) Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174, 192–209.
34. Paik, Y. H., Schwabe, R. F., Bataller, R., Russo, M. P., Jobin, C., Brenner, D. A. (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37, 1043–1055.
35. Watanabe, A., Hashmi, A., Gomes, D. A., Town, T., Badou, A., Flavell, R. A., Mehal, W. Z. (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via Toll-like receptor 9. Hepatology 46, 1509–1518.
36. Wang, N., Liang, Y., Devaraj, S., Wang, J., Lemon, S. M., Li, K. (2009) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J. Virol. 83, 9824–9834.
37. Li, K., Chen, Z., Kato, N., Gale, M. Jr., Lemon, S. M. (2005) Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J. Biol. Chem. 280, 16739–16747.
38. Broering, R., Wu, J., Meng, Z., Hilgard, P., Lu, M., Trippler, M., Szczeponek, A., Gerken, G., Schlaak, J. F. (2008) Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J. Hepatol. 48, 914–922.
39. Foy, E., Li, K., Wang, C., Sumpter, R., Jr., Ikeda, M., Lemon, S. M., Gale, M., Jr. (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145–1148.
40. Otsuka, M., Kato, N., Moriyama, M., Taniguchi, H., Wang, Y., Dharel, N., Kawabe, T., Omata, M. (2005) Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41, 1004–1012.
41. Abe, T., Kaname, Y., Hamamoto, I., Tsuda, Y., Wen, X., Taguwa, S., Moriishi, K., Takeuchi, O., Kawai, T., Kanto, T., Hayashi, N., Akira, S., Matsuura, Y. (2007) Hepatitis C virus nonstructural protein 5A modulates the Toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J. Virol. 81, 8953–8966.
42. Howell, J., Angus, P., Gow, P., Visvanathan, K. (2013) Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment. J. Gastroenterol. Hepatol. 28, 766–776.
43. Yoneyama, M., Fujita, T. (2008) Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29, 178–181.
44. Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., Gale, M., Jr. (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523–527.
45. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., Akira, S. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988.
46. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., Tschopp, J. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.
47. Kwo, P. Y. (2012) Phase III results in genotype 1 naive patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin. Liver Int. 32 (Suppl. 1), 39–43.
48. Shiffman, M. L., Esteban, R. (2012) Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir? Liver Int. 32 (Suppl. 1), 54–60.
49. Kawai, T., Akira, S. (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21, 317–337.
50. Negash, A. A., Ramos, H. J., Crochet, N., Lau, D. T., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., Gale, M., Jr. (2013) IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 9, e1003330.
51. Cerwenka, A., Lanier, L. L. (2001) Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1, 41–49.
52. Corado, J., Toro, F., Rivera, H., Bianco, N. E., Deibis, L., De Sanctis, J. B. (1997) Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin. Exp. Immunol. 109, 451–457.
53. Chan, A., Hong, D. L., Atzberger, A., Kollnberger, S., Filer, A. D., Buckley, C. D., McMichael, A., Enver, T., Bowness, P. (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J. Immunol. 179, 89–94.
54. Meier, U. C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., Klenerman, P., Borrow, P. (2005) Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 79, 12365–12374.
55. Morishima, C., Paschal, D. M., Wang, C. C., Yoshihara, C. S., Wood, B. L., Yeo, A. E., Emerson, S. S., Shuhart, M. C., Gretch, D. R. (2006) Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43, 573–580.
56. Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T., Spengler, U. (2006) Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55, 869–877.
57. Kawarabayashi, N., Seki, S., Hatsuse, K., Ohkawa, T., Koike, Y., Aihara, T., Habu, Y., Nakagawa, R., Ami, K., Hiraide, H., Mochizuki, H. (2000) Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32, 962–969.
58. Golden-Mason, L., Madrigal-Estebas, L., McGrath, E., Conroy, M. J., Ryan, E. J., Hegarty, J. E., O’Farrelly, C., Doherty, D. G. (2008) Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57, 1121–1128.
59. Lin, A. W., Gonzalez, S. A., Cunningham-Rundles, S., Dorante, G., Marshall, S., Tignor, A., Ha, C., Jacobson, I. M., Talal, A. H. (2004) CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection. Clin. Exp. Immunol. 137, 408–416.
60. Crotta, S., Stilla, A., Wack, A., D’Andrea, A., Nuti, S., D’Oro, U., Mosca, M., Filliponi, F., Brunetto, R. M., Bonino, F., Abrignani, S., Valiante, N. M. (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35–41.
61. Tseng, C. T., Klimpel, G. R. (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43–49.
62. De Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S., Mingari, M. C., Moretta, L. (2007) Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 37, 445–455.
63. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Miyagi, T., Suzuki, T., Kanazawa, Y., Hiramatsu, N., Hayashi, N. (2004) Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 173, 6072–6081.
64. Nattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H., Leifeld, L., Weiss, E. H., Sauerbruch, T., Spengler, U. (2005) The HLA-A2 restricted T cell epitope HCV core 35–44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 166, 443–453.
65. Schulte, D., Vogel, M., Langhans, B., Kramer, B., Korner, C., Nischalke, H. D., Steinberg, V., Michalk, M., Berg, T., Rockstroh, J. K., Sauerbruch, T., Spengler, U., Nattermann, J. (2009) The HLA-E(R)/ HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-γ-secreting human CD8(+) T cells. J. Infect. Dis. 200, 1397–1401.
66. O’Doherty, U., Peng, M., Gezelter, S., Swiggard, W. J., Betjes, M., Bhardwaj, N., Steinman, R. M. (1994) Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82, 487–493.
67. Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D. W., Schmitz, J. (2000) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037–6046.
68. Kadowaki, N. (2009) The divergence and interplay between pDC and mDC in humans. Front. Biosci. (Landmark Ed). 14, 808–817.
69. Tavakoli, S., Mederacke, I., Herzog-Hauff, S., Glebe, D., Grun, S., Strand, D., Urban, S., Gehring, A., Galle, P. R., Bocher, W. O. (2008) Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clin. Exp. Immunol. 151, 61–70.
70. Poulin, L. F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J. L., Keller, A. M., Joffre, O., Zelenay, S., Nye, E., Le Moine, A., Faure, F., Donckier, V., Sancho, D., Cerundolo, V., Bonnet, D., Reis e Sousa, C. (2010) Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells. J. Exp. Med. 207, 1261–1271.
71. Perrella, A., Atripaldi, L., Bellopede, P., Patarino, T., Sbreglia, C., Tarantino, G., Sorrentino, P., Conca, P., Ruggiero, L., Perrella, O. (2006) Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms. World J. Gastroenterol. 12, 1105–1109.
72. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M., Bartenschlager, R., Liang, T. J. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791–796.
73. Villacres, M. C., Literat, O., DeGiacomo, M., Du, W., Frederick, T., Kovacs, A. (2008) Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. J. Viral Hepat. 15, 137–144.
74. Kanto, T., Inoue, M., Miyazaki, M., Itose, I., Miyatake, H., Sakakibara, M., Yakushijin, T., Kaimori, A., Oki, C., Hiramatsu, N., Kasahara, A., Hayashi, N. (2006) Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology 49, 58–63.
75. Longman, R. S., Talal, A. H., Jacobson, I. M., Rice, C. M., Albert, M. L. (2005) Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J. Infect. Dis. 192, 497–503.
76. Kanto, T., Inoue, M., Miyatake, H., Sato, A., Sakakibara, M., Yakushijin, T., Oki, C., Itose, I., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N. (2004) Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190, 1919–1926.
77. Wertheimer, A. M., Bakke, A., Rosen, H. R. (2004) Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40, 335–345.
78. Murakami, H., Akbar, S. M., Matsui, H., Horiike, N., Onji, M. (2004) Decreased interferon-α production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin. Exp. Immunol. 137, 559–565.
79. Anthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R., Heinzel, F. P., Lederman, M. M., Lehmann, P. V., Valdez, H. (2004) Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 172, 4907–4916.
80. Piccioli, D., Tavarini, S., Nuti, S., Colombatto, P., Brunetto, M., Bonino, F., Ciccorossi, P., Zorat, F., Pozzato, G., Comar, C., Abrignani, S., Wack, A. (2005) Comparable functions of plasmacytoid and monocyte- derived dendritic cells in chronic hepatitis C patients and healthy donors. J. Hepatol. 42, 61–67.
81. Auffermann-Gretzinger, S., Keeffe, E. B., Levy, S. (2001) Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97, 3171–3176.
82. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trepo, C., Inchauspe, G. (2001) Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120, 512–524.
83. Eksioglu, E. A., Bess, J. R., Zhu, H., Xu, Y., Dong, H. J., Elyar, J., Nelson, D. R., Liu, C. (2010) Hepatitis C virus modulates human monocyte- derived dendritic cells. J. Viral Hepat. 17, 757–769.
84. Dolganiuc, A., Kodys, K., Kopasz, A., Marshall, C., Mandrekar, P., Szabo, G. (2003) Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction. Alcohol Clin. Exp. Res. 27, 1023–1031.
85. Sarobe, P., Lasarte, J. J., Zabaleta, A., Arribillaga, L., Arina, A., Melero, I., Borras-Cuesta, F., Prieto, J. (2003) Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J. Virol. 77, 10862–10871.
86. Szabo, G., Dolganiuc, A. (2005) Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 210, 237–247.
87. Echeverria, I., Zabaleta, A., Silva, L., Diaz-Valdes, N., Riezu-Boj, J. I., Lasarte, J. J., Borras-Cuesta, F., Civeira, M. P., Prieto, J., Sarobe, P. (2008) Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I: C). J. Viral Hepat. 15, 782–789.
88. Brady, M. T., MacDonald, A. J., Rowan, A. G., Mills, K. H. (2003) Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur. J. Immunol. 33, 3448–3457.
89. Bohnenkamp, H. R., Papazisis, K. T., Burchell, J. M., Taylor-Papadimitriou, J. (2007) Synergism of Toll-like receptor-induced interleukin- 12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell. Immunol. 247, 72–84.
90. Miyazaki, M., Kanto, T., Inoue, M., Itose, I., Miyatake, H., Sakakibara, M., Yakushijin, T., Kakita, N., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N. (2008) Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J. Med. Virol. 80, 980–988.
91. Crozat, K., Guiton, R., Contreras, V., Feuillet, V., Dutertre, C. A., Ventre, E., Vu Manh, T. P., Baranek, T., Storset, A. K., Marvel, J., Boudinot, P., Hosmalin, A., Schwartz-Cornil, I., Dalod, M. (2010) The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells. J. Exp. Med. 207, 1283–1292.
92. Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C. J., Dunbar, P. R., Wadley, R. B., Jeet, V., Vulink, A. J., Hart, D. N., Radford, K. J. (2010) Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that crosspresents necrotic cell antigens. J. Exp. Med. 207, 1247–1260.
93. Lauterbach, H., Bathke, B., Gilles, S., Traidl-Hoffmann, C., Luber, C. A., Fejer, G., Freudenberg, M. A., Davey, G. M., Vremec, D., Kallies, A., Wu, L., Shortman, K., Chaplin, P., Suter, M., O’Keeffe, M., Hochrein, H. (2010) Mouse CD8α++ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC. J. Exp. Med. 207, 2703–2717.
94. Zhang, S., Kodys, K., Li, K., Szabo, G. (2013) Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-λ in response to hepatitis C virus infection. Gastroenterology 144, 414–425.e7.
95. Liu, Y. J. (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275–306.
96. Barchet, W., Cella, M., Colonna, M. (2005) Plasmacytoid dendritic cells—virus experts of innate immunity. Semin. Immunol. 17, 253–261.
97. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L., Sisirak, V. (2011) Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163–183.
98. Ulsenheimer, A., Gerlach, J. T., Jung, M. C., Gruener, N., Wachtler, M., Backmund, M., Santantonio, T., Schraut, W., Heeg, M. H., Schirren, C. A., Zachoval, R., Pape, G. R., Diepolder, H. M. (2005) Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41, 643–651.
99. Colonna, M., Trinchieri, G., Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219–1226.
100. Mengshol, J. A., Golden-Mason, L., Castelblanco, N., Im, K. A., Dillon, S. M., Wilson, C. C., Rosen, H. R., Virahep-C Study Group. (2009) Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut 58, 964–973.
101. Barnes, E., Salio, M., Cerundolo, V., Medlin, J., Murphy, S., Dusheiko, G., Klenerman, P. (2004) Impact of α interferon and ribavirin on the function of maturing dendritic cells. Antimicrob. Agents Chemother. 48, 3382–3389.
102. Miyatake, H., Kanto, T., Inoue, M., Sakakibara, M., Kaimori, A., Yakushijin, T., Itose, I., Miyazaki, M., Kuzushita, N., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N. (2007) Impaired ability of interferon- α-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. J. Viral Hepat. 14, 404–412.
103. Dolganiuc, A., Chang, S., Kodys, K., Mandrekar, P., Bakis, G., Cormier, M., Szabo, G. (2006) Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-α and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 177, 6758–6768.
104. Nattermann, J., Zimmermann, H., Iwan, A., von Lilienfeld-Toal, M., Leifeld, L., Nischalke, H. D., Langhans, B., Sauerbruch, T., Spengler, U. (2006) Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44, 945–954.
105. Zimmermann, H. W., Trautwein, C., Tacke, F. (2012) Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front. Physiol. 3, 56.
106. Dolganiuc, A., Norkina, O., Kodys, K., Catalano, D., Bakis, G., Marshall, C., Mandrekar, P., Szabo, G. (2007) Viral and host factors induce macrophage activation and loss of Toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133, 1627–1636.
107. Neuman, M. G., Benhamou, J. P., Bourliere, M., Ibrahim, A., Malkiewicz, I., Asselah, T., Martinot-Peignoux, M., Shear, N. H., Katz, G. G., Akremi, R., Benali, S., Boyer, N., Lecomte, L., Le Breton, V., Le Guludec, G., Marcellin, P. (2002) Serum tumour necrosis factor-α and transforming growth factor-β levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine 17, 108–117.
108. Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M., Mc-Caughan, G. W. (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24, 759–765.
109. Tanaka, Y., Furuta, T., Suzuki, S., Orito, E., Yeo, A. E., Hirashima, N., Sugauchi, F., Ueda, R., Mizokami, M. (2003) Impact of interleukin-1β genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J. Infect. Dis. 187, 1822–1825.
110. Szabo, G., Chang, S., Dolganiuc, A. (2007) Altered innate immunity in chronic hepatitis C infection: cause or effect?. Hepatology 46, 1279–1290.
111. McGuinness, P. H., Painter, D., Davies, S., McCaughan, G. W. (2000) Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46, 260–269.
112. Brenndorfer, E. D., Weiland, M., Frelin, L., Derk, E., Ahlen, G., Jiao, J., Bode, J. G., Sallberg, M. (2010) Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C. Hepatology 52, 1553–1563.
113. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953–964.
114. Biswas, S. K., Chittezhath, M., Shalova, I. N., Lim, J. Y. (2012) Macrophage polarization and plasticity in health and disease. Immunol. Res. 53, 11–24.
115. Doherty, D. G., O’Farrelly, C. (2000) Innate and adaptive lymphoid cells in the human liver. Immunol. Rev. 174, 5–20.
116. Ahmad, A., Alvarez, F. (2004) Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukoc. Biol. 76, 743–759.
117. Yamagiwa, S., Matsuda, Y., Ichida, T., Honda, Y., Takamura, M., Sugahara, S., Ishikawa, T., Ohkoshi, S., Sato, Y., Aoyagi, Y. (2008) Sustained response to interferon-α plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells. Hepatol. Res. 38, 664–672.
118. Brenndorfer, E. D., Sallberg, M. (2012) Hepatitis C virus-mediated modulation of cellular immunity. Arch. Immunol. Ther. Exp. (Warsz). 60, 315–329.
119. Kanto, T., Hayashi, N. (2007) Innate immunity in hepatitis C virus infection: interplay among dendritic cells, natural killer cells and natural killer T cells. Hepatol. Res. 37 (Suppl. 3), S319–S326.
120. Nuti, S., Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., Barnaba, V., Abrignani, S. (1998) Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28, 3448–3455.
121. Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J., Heller, T., Rehermann, B. (2010) Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-α-dependent manner. Gastroenterology 138, 325–335.e1–2.
122. Amadei, B., Urbani, S., Cazaly, A., Fisicaro, P., Zerbini, A., Ahmed, P., Missale, G., Ferrari, C., Khakoo, S. I. (2010) Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138, 1536–1545.
123. Gerosa, F., Gobbi, A., Zorzi, P., Burg, S., Briere, F., Carra, G., Trinchieri, G. (2005) The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174, 727–734.
124. Ebihara, T., Shingai, M., Matsumoto, M., Wakita, T., Seya, T. (2008) Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 48, 48–58.
125. Andrews, D. M., Andoniou, C. E., Scalzo, A. A., van Dommelen, S. L., Wallace, M. E., Smyth, M. J., Degli-Esposti, M. A. (2005) Cross-talk between dendritic cells and natural killer cells in viral infection. Mol. Immunol. 42, 547–555.
126. Jinushi, M., Takehara, T., Kanto, T., Tatsumi, T., Groh, V., Spies, T., Miyagi, T., Suzuki, T., Sasaki, Y., Hayashi, N. (2003) Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170, 1249–1256.
127. Piccioli, D., Sbrana, S., Melandri, E., Valiante, N. M. (2002) Contactdependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335–341.
128. Golden-Mason, L., Rosen, H. R. (2006) Natural killer cells: primary target for hepatitis C virus immune evasion strategies?. Liver Transpl. 12, 363–372.
129. Michel, T., Hentges, F., Zimmer, J. (2013) Consequences of the crosstalk between monocytes/macrophages and natural killer cells. Front. Immunol. 3, 403.
130. Kloss, M., Decker, P., Baltz, K. M., Baessler, T., Jung, G., Rammensee, H. G., Steinle, A., Krusch, M., Salih, H. R. (2008) Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J. Immunol. 181, 6711–6719.
131. Sene, D., Levasseur, F., Abel, M., Lambert, M., Camous, X., Hernandez, C., Pene, V., Rosenberg, A. R., Jouvin-Marche, E., Marche, P. N., Cacoub, P., Caillat-Zucman, S. (2010) Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog. 6, e1001184.
132. Mengshol, J. A., Golden-Mason, L., Arikawa, T., Smith, M., Niki, T., McWilliams, R., Randall, J. A., McMahan, R., Zimmerman, M. A., Rangachari, M., Dobrinskikh, E., Busson, P., Polyak, S. J., Hirashima, M., Rosen, H. R. (2010) A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One 5, e9504.
133. Chattergoon, M. A., Levine, J. S., Latanich, R., Osburn, W. O., Thomas, D. L., Cox, A. L. (2011) High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection. J. Infect. Dis. 204, 1730–1740.
134. Krishnadas, D. K., Ahn, J. S., Han, J., Kumar, R., Agrawal, B. (2010) Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms. Int. Immunol. 22, 491–502.
135. Rehermann, B. (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119, 1745–1754.
136. Zhang, S., Saha, B., Kodys, K., Szabo, G. (2013) IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells. J. Hepatol. 59, 442–449.
137. Serti, E., Werner, J. M., Chattergoon, M., Cox, A. L., Lohmann, V., Rehermann, B. (2014) Monocytes activate natural killer cells via inflammasome- induced interleukin 18 in response to hepatitis C virus replication. Gastroenterology 147, 209–220.e3.